Cite
Methodological and Regulatory Considerations for Updated Guidance on the Pressor Effects of Drugs.
MLA
Harrison, Nicholas R., et al. “Methodological and Regulatory Considerations for Updated Guidance on the Pressor Effects of Drugs.” Therapeutic Innovation & Regulatory Science, vol. 54, no. 6, Nov. 2020, pp. 1473–76. EBSCOhost, https://doi.org/10.1007/s43441-020-00174-8.
APA
Harrison, N. R., Sager, P. T., Krucoff, M. W., Weber, M. A., & White, W. B. (2020). Methodological and Regulatory Considerations for Updated Guidance on the Pressor Effects of Drugs. Therapeutic Innovation & Regulatory Science, 54(6), 1473–1476. https://doi.org/10.1007/s43441-020-00174-8
Chicago
Harrison, Nicholas R, Philip T Sager, Mitchell W Krucoff, Michael A Weber, and William B White. 2020. “Methodological and Regulatory Considerations for Updated Guidance on the Pressor Effects of Drugs.” Therapeutic Innovation & Regulatory Science 54 (6): 1473–76. doi:10.1007/s43441-020-00174-8.